Trial Profile
A Randomised, Placebo Controlled Trial of Azithromycin for the Prevention of Chronic Lung Disease of Prematurity in Preterm Infants
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Therapeutic Use
- Acronyms TINN2
- 22 Jun 2016 This trial was prematurely ended in Hungary according to the European Clinical Trials Database.
- 09 May 2016 New trial record